cedazuridine; decitabine
Generic: CEDAZURIDINE; DECITABINE·Brand: INQOVI
cedazuridine; decitabine: 1 clinical trial tracked.
cedazuridine; decitabine evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about cedazuridine; decitabine, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
An Open-label, Multicenter, Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
Primary endpoint: Number of participants with Adverse Events (AEs) and Serious Adverse Events (SAEs)
Interventionalopen33 enrolledStarted 2023-02Completion 2028-0224 sites · Australia, Brazil, Canada, China…Novartis Pharmaceuticals